eMedicine Specialties > Urology > Surgery

Urinary Diversions and Neobladders: Workup

Author: Joseph A Costa, DO, Chief, Division of Urology, University of Florida / Shands Jacksonville
Coauthor(s): Karl Kreder, MD, Vice-Chairman, Director of Urodynamics and Reconstructive Surgery, Professor, Department of Urology, University of Iowa College of Medicine
Contributor Information and Disclosures

Updated: Dec 9, 2008

Workup

Laboratory Studies

  • Prior to urinary diversion, assessment of the patient's renal function is important.
    • Most consider a minimum creatinine clearance of 60 mL/min necessary prior to performing continent diversion.
    • A minimum of renal function is necessary because of the increased renal demand created by continent urinary diversion.
    • Because of the increased contact time of urine with bowel segments, previously eliminated renal products are reabsorbed and must again be reexcreted.
  • Laboratory studies for patients with urinary diversion should be primarily directed toward excluding infection and assessing metabolic status, specifically metabolic acidosis because of concerns discussed in Pathophysiology. The following laboratory studies are suggested:
    • Arterial blood gas (if significant metabolic acidosis is expected)
    • Acid-base disturbance graph
    • Acid-base nomogram (may be found at via the National Center of Emergency Medicine Informatics at www.ncemi.org/etools/datafiles/acid-base_disturbance_graph.gif)
    • Complete blood cell count
    • Urinalysis and urine culture (if indicated)
    • Electrolytes, BUN, and creatinine

Imaging Studies

  • Ultrasonography
    • Ultrasonography is a desirable method for imaging the upper urinary tracts because it requires no nephrotoxic agents.
    • Ultrasonography is most useful if findings are completely normal or if no change from prior multiple studies is demonstrated upon comparison.
    • Keep in mind that the appearance of hydronephrosis or hydroureteronephrosis does not always indicate obstruction. Surgeons commonly perform "nonrefluxing" ureteral anastomoses, which may result in an ultrasonographic image similar to that of an obstruction. One must consider if a "physiologic" antegrade study is indicated in conjunction with ultrasonography to definitively rule out obstruction.
    • Mild-to-moderate hydronephrosis in a patient with urinary diversion is not unusual, especially with a noncontinent conduit.
    • Remember that ultrasonography offers no information on the physiologic drainage of the urinary system.
  • Intravenous pyelography
    • Most urologists are comfortable with the anatomical information obtained from an intravenous pyelography (IVP). Depending on the evaluating physician's preference, IVP is an excellent method of imaging the integrity and drainage of the upper urinary system.
    • The major drawback of this test is with a patient who is either allergic to intravenous contrast or is azotemic; however, in the absence of these two limitations, this is the study of choice for evaluating a patient for a urinary diversion procedure.
  • Nuclear scan
    • Mercaptotriglycylglycine or diethylenetriamine pentaacetic acid is an excellent imaging agent for assessing renal function and drainage.
    • Drainage is better assessed with the addition of a Lasix injection after accumulation of tracer in the collecting systems.
    • The main drawback to nuclear imaging is the lack of information obtained regarding the precise location of obstruction or integrity of the urinary tract.
  • CT scanning
    • Noncontrast CT scanning is most useful for demonstrating the presence of urinary calculi; if absent, performing a contrast-enhanced study alone or after noncontrast images is probably more useful for assessing drainage, function, and integrity.
    • CT scanning is extremely valuable for assessing a ruptured continent urinary reservoir or for determining the presence of fistulous communication of the urinary tract with the gastrointestinal or genital tracts.
  • MRI
    • MRI is rarely indicated in an evaluation for urinary diversion. The most likely indication is to rule out recurrent cancer in a patient who has equivocal CT scan findings.
    • The other potential use for MRI is using gadolinium for imaging the drainage of a tract in a patient who is azotemic or allergic to intravenous contrast.
  • Cystography
    • Distension of the continent reservoir with contrast is indicated when the patient is thought to have a ruptured segment. The reservoir must be assessed in at least two views, and the conduit must be adequately distended.
    • Redundant folds of bowel are not uncommon after a continent diversion has been fashioned. With this in mind, ensuring that those redundant folds are adequately distended is important for excluding rupture. A good rule of thumb is to ask the patient how much urine is normally obtained with each void or catheterization.
    • Cystography to rule out a rupture is best performed under real-time imaging, thereby allowing the reservoir to be monitored throughout the entire distension phase.

Other Tests

  • Urodynamic studies
    • Urodynamic studies of continent bowel segments have been performed and reported in the medical literature.
    • Few clinical indications exist for urodynamic studies, with the exception of treating a patient with a continent urinary diversion and unrelenting incontinence.

Diagnostic Procedures

  • To determine the etiology for which urinary diversion is required, CT scanning, MRI, ultrasonography, IVP, and urodynamic studies play specific roles in helping determine the presence of malignancy, urinary tract obstruction, or urine storage abnormalities. All of these conditions may be harmful to the patient's future renal function.

Histologic Findings

Abnormal histologic findings are uncommon in diversion procedures because the pathologic bladder specimen is removed. Rarely, a biopsy is performed on the intestinal segments that have replaced the bladder. For further information on the histopathologic findings of bladder tumors, refer to Bladder Cancer.

More on Urinary Diversions and Neobladders

Overview: Urinary Diversions and Neobladders
Workup: Urinary Diversions and Neobladders
Treatment: Urinary Diversions and Neobladders
Follow-up: Urinary Diversions and Neobladders
Multimedia: Urinary Diversions and Neobladders
References

References

  1. Ferris DO, Odel HM. Electrolyte pattern of the blood after bilateral ureterosigmoidostomy. J Am Med Assoc. Mar 4 1950;142(9):634-41. [Medline].

  2. Haupt G, Pannek J, Knopf HJ, eet al. Rupture of ileal neobladder due to urethral obstruction by mucous plug. J Urol. Sep 1990;144(3):740-1. [Medline].

  3. Pannek J, Haupt G, Schulze H, et al. Influence of continent ileal urinary diversion on vitamin B12 absorption. J Urol. Apr 1996;155(4):1206-8. [Medline].

  4. Benson MC, Olsson CA. Walsh PC, Retik AB, Vaughan ED, Wein AJ, eds. Campbell's Urology. 7th ed. Philadelphia, Pa: WB Saunders; 1998:3190-227.

  5. Brand E. Cecal rupture after continent ileocecal urinary diversion during total pelvic exenteration. Obstet Gynecol. Sep 1991;78(3 Pt 2):570-2. [Medline].

  6. Elder JS, Snyder HM, Hulbert WC, et al. Perforation of the augmented bladder in patients undergoing clean intermittent catheterization. J Urol. Nov 1988;140(5 Pt 2):1159-62. [Medline].

  7. Farnham SB, Cookson MS. Surgical complications of urinary diversion. World J Urol. Sep 2004;22(3):157-67. [Medline].

  8. Gittes RF. Carcinogenesis in ureterosigmoidostomy. Urol Clin North Am. May 1986;13(2):201-5. [Medline].

  9. Golimbu M, Morales P. Jejunal conduits: technique and complications. J Urol. Jun 1975;113(6):787-95. [Medline].

  10. Hadley MN, Zabramski JM, Browner CM, et al. Pediatric spinal trauma. Review of 122 cases of spinal cord and vertebral column injuries. J Neurosurg. Jan 1988;68(1):18-24. [Medline].

  11. Lee KS, Montie JE, Dunn RL, et al. Hautmann and Studer orthotopic neobladders: a contemporary experience. J Urol. Jun 2003;169(6):2188-91. [Medline].

  12. Lloyd LK, Kuhlemeier KV, Fine PR. Initial bladder management in spinal cord injury: does it make a difference?. J Urol. Mar 1986;135(3):523-7. [Medline].

  13. McDougal WS, Stampfer DS, Kirley S, et al. Intestinal ammonium transport by ammonium and hydrogen exchange. J Am Coll Surg. Sep 1995;181(3):241-8. [Medline].

  14. McGuire EJ, Woodside JR, Borden TA, et al. Prognostic value of urodynamic testing in myelodysplastic patients. J Urol. Aug 1981;126(2):205-9. [Medline].

  15. Pekarovic E, Robinson A, Lister J, et al. Pressure variations in intestinal loops used for urinary diversion. Dev Med Child Neurol. 1968;Suppl 16:87+. [Medline].

  16. Rogers AC, Steyn JH. Vitamin B12 absorption in patients with ileal resection. Br J Urol. Dec 1974;46(6):625-9. [Medline].

  17. Roosen A, Gerharz EW, Roth S, et al. Bladder, bowel and bones--skeletal changes after intestinal urinary diversion. World J Urol. Sep 2004;22(3):200-9. [Medline].

  18. Smith EM, Bodner DR. Sexual dysfunction after spinal cord injury. Urol Clin North Am. Aug 1993;20(3):535-42. [Medline].

  19. Steiner MS, Morton RA, Marshall FF. Vitamin B12 deficiency in patients with ileocolic neobladders. J Urol. Feb 1993;149(2):255-7. [Medline].

  20. Wang SC, McGuire EJ, Bloom DA. A bladder pressure management system for myelodysplasia--clinical outcome. J Urol. Dec 1988;140(6):1499-502. [Medline].

  21. Williams O, Vereb MJ, Libertino JA. Noncontinent urinary diversion. Urol Clin North Am. Nov 1997;24(4):735-44. [Medline].

Further Reading

Keywords

urinary diversion, neobladder, urinary tract diversion, urinary conduit, orthotopic diversion, continent catheterizable diversion, ostomy, stoma, ureteroproctostomy, ureterosigmoidostomy, rectal bladder, ileal loop, ileal neobladder, Koch pouch, Indiana pouch, continent diversion, noncontinent diversion, continent urinary diversion, noncontinent urinary diversion, continent urinary tract diversion, noncontinent urinary tract diversion, cutaneous ureterostomy, neobladder diversion, continent catheterizable diversion, urinary system diversion

Contributor Information and Disclosures

Author

Joseph A Costa, DO, Chief, Division of Urology, University of Florida / Shands Jacksonville
Joseph A Costa, DO is a member of the following medical societies: American Urological Association
Disclosure: Coloplast Consulting fee None; Pfizer Honoraria None

Coauthor(s)

Karl Kreder, MD, Vice-Chairman, Director of Urodynamics and Reconstructive Surgery, Professor, Department of Urology, University of Iowa College of Medicine
Karl Kreder, MD is a member of the following medical societies: Alpha Omega Alpha and American Urological Association
Disclosure: Nothing to disclose.

Medical Editor

Erik T Goluboff, MD, Professor, Department of Urology, College of Physicians and Surgeons, Columbia University; Director of Urology, Allen Pavilion, New York Presbyterian Hospital
Erik T Goluboff, MD is a member of the following medical societies: Alpha Omega Alpha, American Medical Association, American Urological Association, Medical Society of the State of New York, New York Academy of Medicine, Phi Beta Kappa, and Society for Basic Urologic Research
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

Managing Editor

Dan Theodorescu, MD, PhD, Paul Mellon Professor of Urologic Oncology, Department of Urology, University of Virginia Health Sciences Center
Dan Theodorescu, MD, PhD is a member of the following medical societies: American Cancer Society, American College of Surgeons, American Urological Association, Medical Society of Virginia, Society for Basic Urologic Research, and Society of Urologic Oncology
Disclosure: Nothing to disclose.

CME Editor

J Stuart Wolf Jr, MD, FACS, David A Bloom Professor of Urology, Director of Division of Minimally Invasive Urology, Department of Urology, University of Michigan
J Stuart Wolf Jr, MD, FACS is a member of the following medical societies: American College of Surgeons, American Urological Association, Catholic Medical Association, Endourological Society, Society for Urology and Engineering, Society of Laparoendoscopic Surgeons, Society of University Urologists, and Society of Urologic Oncology
Disclosure: Terumo Corporation Consulting fee Consulting; Omeros Corporation Consulting fee Consulting

Chief Editor

Bradley Fields Schwartz, DO, FACS, Associate Professor of Urology, Director, Center for Laparoscopy and Endourology, Department of Surgery, Southern Illinois University School of Medicine
Bradley Fields Schwartz, DO, FACS is a member of the following medical societies: American College of Surgeons, American Urological Association, Association of Military Osteopathic Physicians and Surgeons, Endourological Society, Society of Laparoendoscopic Surgeons, and Society of University Urologists
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.